In contrast, Talin-1 expression was reduced in malignancy and did not demonstrate statistical significance in adenocarcinoma (χ2 = 2.11, p = 0.146), squamous cell carcinoma (χ2 = 0.01, p = 0.912), or NSCLC overall (χ2 = 1.12, p = 0.289). The gene discussed is TLN1; the disease is adenocarcinoma.